Oscar Health reconfirms FY2024 guidance, to provide updated strategic targets at Investor Day

Oscar Health, Inc.

Reaffirms full-year 2024 guidance as provided in Q4 2023 earnings release dated Feb 7, 2024.
Will update on Adjusted EBITDA performance through April 30, 2024.
To discuss long-term growth targets and strategic levers at June 7 Investor Day.

item 7.01

Oscar Health, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-24-156438

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.